FDA 510(k)

ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS

K-Number: K973707 · 1999-08-04

Decision Date1999-08-04

Product CodeMKZ

Advisory CommitteeMI

DecisionSubstantially Equivalent

Device Summary

ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS is the device name listed in this FDA 510(k) record. The listed applicant is Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 1999-08-04 under 510(k) number K973707. The device is classified under product code MKZ. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS?

ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS is a medical device that received FDA 510(k) clearance on 1999-08-04. The listed applicant is Roche Molecular Systems, Inc.. The 510(k) number is K973707.

When did ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS receive FDA 510(k) clearance?

ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS received FDA 510(k) clearance on 1999-08-04, under 510(k) number K973707.

Who is the listed applicant for ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS?

The FDA 510(k) record lists Roche Molecular Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS?

The FDA product code for ROCHE AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS is MKZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Roche Molecular Systems, Inc. as applicant

K260047cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas Strep A Quality Control Kit (07402678190)K260045cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative Control Kit for use on the cobas® Liat® System (07454970190)K260021cobas® BV/CV K260917cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems K253756cobas liat CT/NG nucleic acid test K253759cobas liat CT/NG/MG nucleic acid test

View all 48 devices →

Related Devices (Code: MKZ)

K230451Aptima® Chlamydia trachomatis AssayHologic, Inc.K110923COBAS 4800 CT / NG TESTRoche Molecular Systems, Inc.K091724BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAYBecton, Dickinson & CO K090824BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAYBecton, Dickinson & CO K081824BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAYBecton, Dickinson & CO K080739ABBOTT REALTIME CT/NG ASSAY AND MULTI-COLLECT SPECIMEN COLLECTION KITAbbott Molecular, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.